186 related articles for article (PubMed ID: 33382965)
1. Serum myeloid-related protein 8/14 is a potential predictor of diabetic kidney disease.
Gu W; Cui J; Shi M; Zhang R; Tan D; Zhang X; Zhang H
Discov Med; 2020; 30(160):97-105. PubMed ID: 33382965
[TBL] [Abstract][Full Text] [Related]
2. Serum Elabela/Toddler Levels Are Associated with Albuminuria in Patients with Type 2 Diabetes.
Zhang H; Gong D; Ni L; Shi L; Xu W; Shi M; Chen J; Ai Y; Zhang X
Cell Physiol Biochem; 2018; 48(3):1347-1354. PubMed ID: 30048993
[TBL] [Abstract][Full Text] [Related]
3. Levels of Serum 25(OH)VD3, HIF-1α, VEGF, vWf, and IGF-1 and Their Correlation in Type 2 Diabetes Patients with Different Urine Albumin Creatinine Ratio.
Shao Y; Lv C; Yuan Q; Wang Q
J Diabetes Res; 2016; 2016():1925424. PubMed ID: 27069929
[TBL] [Abstract][Full Text] [Related]
4. Increased serum myeloid-related protein 8/14 level is associated with atherosclerosis in type 2 diabetic patients.
Peng WH; Jian WX; Li HL; Hou L; Wei YD; Li WM; Xu YW
Cardiovasc Diabetol; 2011 May; 10():41. PubMed ID: 21592353
[TBL] [Abstract][Full Text] [Related]
5. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function.
Chen CC; Susanto H; Chuang WH; Liu TY; Wang CH
Cardiovasc Diabetol; 2016 Jan; 15():3. PubMed ID: 26739836
[TBL] [Abstract][Full Text] [Related]
6. The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin.
Wu C; Wang Q; Lv C; Qin N; Lei S; Yuan Q; Wang G
Diabetes Res Clin Pract; 2014 Nov; 106(2):343-50. PubMed ID: 25263500
[TBL] [Abstract][Full Text] [Related]
7. Serum and Urinary Progranulin in Diabetic Kidney Disease.
Nicoletto BB; Krolikowski TC; Crispim D; Canani LH
PLoS One; 2016; 11(10):e0165177. PubMed ID: 27776152
[TBL] [Abstract][Full Text] [Related]
8. Myeloid-related protein 8/14 complex describes microcirculatory alterations in patients with type 2 diabetes and nephropathy.
Burkhardt K; Schwarz S; Pan C; Stelter F; Kotliar K; Von Eynatten M; Sollinger D; Lanzl I; Heemann U; Baumann M
Cardiovasc Diabetol; 2009 Feb; 8():10. PubMed ID: 19232095
[TBL] [Abstract][Full Text] [Related]
9. Plasma Leucine-Rich α-2-Glycoprotein 1 Predicts Rapid eGFR Decline and Albuminuria Progression in Type 2 Diabetes Mellitus.
Liu JJ; Pek SLT; Ang K; Tavintharan S; Lim SC;
J Clin Endocrinol Metab; 2017 Oct; 102(10):3683-3691. PubMed ID: 28973352
[TBL] [Abstract][Full Text] [Related]
10. Association of Serum Amyloid A with Kidney Outcomes and All-Cause Mortality in American Indians with Type 2 Diabetes.
Saulnier PJ; Dieter BP; Tanamas SK; McPherson SM; Wheelock KM; Knowler WC; Looker HC; Meek RL; Nelson RG; Tuttle KR
Am J Nephrol; 2017; 46(4):276-284. PubMed ID: 28934744
[TBL] [Abstract][Full Text] [Related]
11. Level of urinary liver-type fatty acid-binding protein is associated with cardiac markers and electrocardiographic abnormalities in type-2 diabetes with chronic kidney disease stage G1 and G2.
Maeda Y; Suzuki A; Ishii J; Sekiguchi-Ueda S; Shibata M; Yoshino Y; Asano S; Hayakawa N; Nakamura K; Akiyama Y; Kitagawa F; Sakuishi T; Fujita T; Hashimoto S; Ozaki Y; Itoh M
Heart Vessels; 2015 May; 30(3):362-8. PubMed ID: 24626813
[TBL] [Abstract][Full Text] [Related]
12. Comparison of serum and urinary biomarker panels with albumin/creatinine ratio in the prediction of renal function decline in type 1 diabetes.
Colombo M; McGurnaghan SJ; Blackbourn LAK; Dalton RN; Dunger D; Bell S; Petrie JR; Green F; MacRury S; McKnight JA; Chalmers J; Collier A; McKeigue PM; Colhoun HM;
Diabetologia; 2020 Apr; 63(4):788-798. PubMed ID: 31915892
[TBL] [Abstract][Full Text] [Related]
13. FABP1 and FABP2 as markers of diabetic nephropathy.
Tsai IT; Wu CC; Hung WC; Lee TL; Hsuan CF; Wei CT; Lu YC; Yu TH; Chung FM; Lee YJ; Wang CP
Int J Med Sci; 2020; 17(15):2338-2345. PubMed ID: 32922199
[No Abstract] [Full Text] [Related]
14. Vascular inflammation, atherosclerosis, and lipid metabolism and the occurrence of non-high albuminuria diabetic kidney disease: A cross-sectional study.
Yang Y; Xu P; Liu Y; Chen X; He Y; Feng J
Diab Vasc Dis Res; 2021; 18(1):1479164121992524. PubMed ID: 33567895
[TBL] [Abstract][Full Text] [Related]
15. TNF-α and microalbuminuria in patients with type 2 diabetes mellitus.
Lampropoulou IT; Stangou M; Papagianni A; Didangelos T; Iliadis F; Efstratiadis G
J Diabetes Res; 2014; 2014():394206. PubMed ID: 25587544
[TBL] [Abstract][Full Text] [Related]
16. Expression levels of serum vasohibin-1 and other biomarkers in type 2 diabetes mellitus patients with different urinary albumin to creatinine ratios.
Ren H; Shao Y; Ma X; Yang M; Liu Y; Wang Q
J Diabetes Complications; 2019 Jul; 33(7):477-484. PubMed ID: 31097304
[TBL] [Abstract][Full Text] [Related]
17. Microalbuminuria, Other Markers of Nephropathy and Biochemical Derangementsin Type 2 Diabetes Mellitus: Relationships and Determinants.
Idowu AA; Ajose AO; Adedeji AT; Adegoke AO; Jimoh KA
Ghana Med J; 2017 Jun; 51(2):56-63. PubMed ID: 28955101
[TBL] [Abstract][Full Text] [Related]
18. Diabetic Nephropathy Can Be Treated with Calcium Dobesilate by Alleviating the Chronic Inflammatory State and Improving Endothelial Cell Function.
Zhou Y; Qi C; Li S; Shao X; Mou S; Ni Z
Cell Physiol Biochem; 2018; 51(3):1119-1133. PubMed ID: 30476916
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress markers in type 2 diabetes patients with diabetic nephropathy.
Chou ST; Tseng ST
Clin Exp Nephrol; 2017 Apr; 21(2):283-292. PubMed ID: 27233502
[TBL] [Abstract][Full Text] [Related]
20. Assessment of urinary NGAL for differential diagnosis and progression of diabetic kidney disease.
Duan S; Chen J; Wu L; Nie G; Sun L; Zhang C; Huang Z; Xing C; Zhang B; Yuan Y
J Diabetes Complications; 2020 Oct; 34(10):107665. PubMed ID: 32653382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
